Tag Archives: EQIX

Hot Medical Stocks To Buy Right Now

Big changes are under way right now in our neighbor to the north. Beginning Oct. 17, recreational marijuana will officially go on sale in Canada, making it the first industrialized country in the world to give adult-use weed the green light.

The legalization of marijuana in Canada is expected to generate up to $5 billion in annual sales once the industry is fully up to speed. Though some of this revenue will come from domestic markets, Canadian growers are angling to reap significant rewards from exports since roughly 30 countries having legalized medical cannabis to some degree. However, the United States won’t be one of those countries.

Image source: Getty Images.

The U.S. federal government stymies cannabis progress

Whereas most of the developed world appears to be progressing on their view of cannabis, the U.S. has remained stuck in neutral. Even though Oklahoma recently became the 30th state to have legalized medical marijuana in some capacity, the federal government has held firm on its stance that cannabis is a Schedule I substance. According to the Controlled Substances Act, that means marijuana is entirely illegal, prone to abuse, and devoid of any recognized medical benefits.

Hot Medical Stocks To Buy Right Now: Equinix Inc.(EQIX)

Advisors’ Opinion:

  • [By Lee Jackson]

    This is one of the larger capitalization companies in the data center industry. Equinix Inc. (NASDAQ: EQIX) provides data center services to protect and connect the information assets for the enterprises, financial services companies, and content and network providers primarily in the Americas, Europe, the Middle East, Africa and the Asia-Pacific.

  • [By Stephan Byrd]

    Credit Suisse Group set a $525.00 price objective on Equinix (NASDAQ:EQIX) in a research report report published on Friday. The firm currently has a buy rating on the financial services provider’s stock.

  • [By Beth McKenna]

    Equinix (NASDAQ:EQIX) reported robust first-quarter 2018 financial results after the market close on Wednesday. 

    Shares closed down 6.1% on Thursday, which we can probably attribute to the company revising slightly downward its full-year 2018 adjusted funds from operations (AFFO) outlook, as we’ll get to in a moment. (AFFO is a closely watched metric for companies organized as real estate investment trusts, or REITs. It’s akin to “earnings” for REITs.) 

Hot Medical Stocks To Buy Right Now: Harte-Hanks, Inc.(HHS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Bioblast Pharma Ltd. (NASDAQ: ORPN) shares rose 29.6 percent to $3.22.
    Mannatech, Incorporated (NASDAQ: MTEX) surged 23.3 percent to $19.60 after the company reported commencement of modified Dutch auction cash tender for up to $16 million of common stock.
    Evolus, Inc. (NASDAQ: EOLS) shares rose 22.1 percent to $15.8003.
    Quotient Limited (NASDAQ: QTNT) gained 18.1 percent to $5.54 following commencement of EU blood grouping field trial.
    Shineco, Inc. (NASDAQ: TYHT) climbed 17.1 percent to $1.9899 following Q3 results. Shineco posted Q3 earnings of $0.21 per share on sales of $13.3 million.
    CPI Card Group Inc. (NASDAQ: PMTS) rose 17 percent to $3.0999.
    Dover Downs Gaming & Entertainment, Inc. (NYSE: DDE) shares climbed 12 percent to $2.2613. The stock spiked more than 14 percent Thursday near the close as traders circulate word the Delaware lottery is planning to introduce full sports betting in June.
    Harte Hanks, Inc. (NYSE: HHS) shares gained 7.2 percent to $11.05 after the company late Thursday appointed four new independent directors to board.
    Cronos Group Inc. (NASDAQ: CRON) rose 6.4 percent to $6.17.
    VivoPower International PLC (NASDAQ: VVPR) shares gained 6.3 percent to $3.74.
    Global Self Storage, Inc. (NASDAQ: SELF) shares climbed 6 percent to $4.20.

    Check out these big penny stock gainers and losers

  • [By Ethan Ryder]

    ValuEngine upgraded shares of Harte Hanks (NYSE:HHS) from a sell rating to a hold rating in a research report sent to investors on Monday.

    HHS has been the topic of a number of other reports. Noble Financial reaffirmed a buy rating on shares of Harte Hanks in a research note on Monday, March 5th. Zacks Investment Research raised shares of Harte Hanks from a hold rating to a strong-buy rating and set a $12.00 target price on the stock in a research note on Tuesday, May 15th.

  • [By Logan Wallace]

    These are some of the news stories that may have effected Accern’s rankings:

    Get Harte Hanks alerts:

    Harte-Hanks (HHS) Name Four New Independent Directors (streetinsider.com) Harte Hanks (HHS) Given $15.00 Consensus Price Target by Brokerages (americanbankingnews.com) Harte Hanks to Appoint Four New Independent Directors to the Board (feeds.benzinga.com) Harte Hanks (HHS) Stock Rating Upgraded by Zacks Investment Research (americanbankingnews.com) Harte Hanks (HHS) Shares March Higher, Can It Continue? (zacks.com)

    Shares of Harte Hanks traded up $0.65, reaching $10.96, during trading hours on Friday, according to Marketbeat.com. The stock had a trading volume of 46,930 shares, compared to its average volume of 18,474. Harte Hanks has a 12 month low of $7.30 and a 12 month high of $14.40. The stock has a market capitalization of $64.54 million, a price-to-earnings ratio of -9.13 and a beta of 0.90.

  • [By Ethan Ryder]

    ValuEngine upgraded shares of Harte Hanks (NYSE:HHS) from a strong sell rating to a sell rating in a research report report published on Friday morning.

  • [By Logan Wallace]

    Noble Financial reissued their buy rating on shares of Harte Hanks (NYSE:HHS) in a report issued on Thursday.

    HHS has been the topic of a number of other research reports. ValuEngine upgraded shares of Harte Hanks from a strong sell rating to a sell rating in a report on Tuesday, August 28th. Zacks Investment Research cut shares of Harte Hanks from a hold rating to a strong sell rating in a report on Tuesday, August 14th.

Hot Medical Stocks To Buy Right Now: Durect Corporation(DRRX)

Advisors’ Opinion:

  • [By Brian Orelli]

    DURECT Corp. (NASDAQ:DRRX) is down 9.2% at 12:45 p.m. EDT after the U.S. Food and Drug Administration’s advisory committee voted 14 to 3 recommending the agency not approve Remoxy ER, an abuse-deterrent extended-release pain medication being developed by its partner Pain Therapeutics (NASDAQ: PTIE).

  • [By Shane Hupp]

    Headlines about DURECT (NASDAQ:DRRX) have been trending somewhat positive on Friday, according to Accern Sentiment. The research firm identifies positive and negative news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. DURECT earned a media sentiment score of 0.11 on Accern’s scale. Accern also assigned news headlines about the specialty pharmaceutical company an impact score of 47.6857828380145 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on DURECT (DRRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on DURECT (DRRX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Medical Stocks To Buy Right Now: American Airlines Group, Inc.(AAL)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage loss in the S&P 500 ahead of the close was American Airlines Group Inc. (NASDAQ: AAL) which fell about 8% to $36.00. The stock’s 52-week range is $35.90 to $59.08. Volume was 24 million compared to the daily average volume of 6.2 million.

  • [By Chris Dier-Scalise]

    More evidence of strength in the contractors can be seen in a uptick in both government and private contracts. Boeing might be winner of the most high-profile and sizable agreements, recently winning both a $3.9 billion contract to modernize the Air Force One fleet as well as a deal with American Airlines Group Inc (NYSE: AAL) for 47 planes valued at $12 billion.

  • [By Lisa Levin]

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

    Before the markets open, Bristol-Myers Squibb Company (NYSE: BMY) is projected to report quarterly earnings at $0.85 per share on revenue of $5.24 billion. Bristol-Myers shares rose 0.95 percent to $52.25 in after-hours trading.
    AT&T Inc. (NYSE: T) reported weaker-than-expected earnings

  • [By Adam Levine-Weinberg]

    Not surprisingly, the airlines with the lowest profit margins have been hit hardest. These carriers are the most vulnerable to fuel price increases and demand shocks, as small changes in their profit margins can severely impact their earnings. During the past year, American Airlines (NASDAQ:AAL) has fallen into the bottom echelon of U.S. airlines in terms of profitability, and so its share price tumbled 7.5% in the first three days of this week.

Hot Medical Stocks To Buy Right Now: Hibbett Sports Inc.(HIBB)

Advisors’ Opinion:

  • [By Shane Hupp]

    Trexquant Investment LP acquired a new stake in shares of Hibbett Sports (NASDAQ:HIBB) during the 1st quarter, according to its most recent disclosure with the SEC. The fund acquired 12,159 shares of the company’s stock, valued at approximately $291,000.

  • [By Shane Hupp]

    Canaccord Genuity downgraded shares of Hibbett Sports (NASDAQ:HIBB) from a buy rating to a hold rating in a research report released on Monday, MarketBeat.com reports. The firm currently has $21.00 target price on the stock, down from their prior target price of $31.00.

  • [By Dan Caplinger]

    Wall Street had a major celebration on Friday, as the S&P 500 finished at an all-time high for the first time in roughly seven months. Investors generally pointed to Federal Reserve Chairman Jerome Powell’s comments that suggested that a gradual pace of future interest rate increases was the most likely scenario for the U.S. credit markets. The prospects for predictable monetary policy moves was a positive for the market overall, but there were still some companies that dealt with specific bad news that hurt their individual stock prices. Foot Locker (NYSE:FL), Hibbett Sports (NASDAQ:HIBB), and Grupo Supervielle (NYSE:SUPV) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Motley Fool Transcribers]

    Hibbett Sports Inc (NASDAQ:HIBB)Q2 2019 Earnings Conference CallAug. 24, 2018, 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Hibbett Sports, Inc. (NASDAQ:HIBB) has received a consensus rating of “Hold” from the nineteen research firms that are covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and six have issued a buy rating on the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $21.23.

  • [By Lisa Levin]

    Breaking news

    Foot Locker, Inc. (NYSE: FL) reported better-than-expected results for its first quarter.
    Hibbett Sports, Inc. (NASDAQ: HIBB) reported weaker-than-expected results for its first quarter.
    Ross Stores, Inc. (NASDAQ: ROST) reported upbeat earnings for its first quarter, but issued weak forecast for the current quarter.
    Gap Inc (NYSE: GPS) posted downbeat earnings for its first quarter on Thursday. Comps were up 1 percent in the quarter.

Top Stocks To Watch Right Now

Angel Commodities’ report on Gold

On Wednesday, spot gold prices rose 0.3 percent to close at $ 1299.3 per ounce as weakness in the DX ahed of FOMC state men t buoyed the yellow metal. Earlier this week, the dollar strengthened following a positive U.S. – North Korea summit, with markets now waiting for a likely interest rate hike by the U.S. Federal Reserve. The dollar hit a three – week high against the yen on Tuesday and Asian shares gained as U.S. President Donald Trump and North Korean leader Kim Jong Un signed a “comprehensive” deal at a historic summit aimed at the denuclearisation of the Korean peninsula. MCX gold prices declined marginally to close at Rs.31143/10gms on Wednesday.

Outlook
Gold prices are likely to trade lower after the widely expected rate hike announcement by the Federal Reserve amidst strong inflation and jobs numbers. On the MCX, gold prices are expected to trade lower today, international markets are trading marginally lower at $ 1298.3 per ounce.

For all commodities report, click here

Top Stocks To Watch Right Now: RXI Pharmaceuticals Corporation(RXII)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    MoSys, Inc. (NASDAQ: MOSY) shares rose 44.7 percent to $2.20 in pre-market trading after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    The Trade Desk, Inc. (NASDAQ: TTD) rose 23.2 percent to $65.01 in pre-market trading after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    Immersion Corporation (NASDAQ: IMMR) rose 17 percent to $13.55 in pre-market trading after reporting upbeat Q1 results.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) rose 13.8 percent to $23.50 in pre-market trading after the company disclosed that the FDA Advisory Committee voted in favor of WAYLIVRA for the treatment of familial chylomicronemia syndrome.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 9.4 percent to $2.45 in pre-market trading after the company disclosed a collaboration with Iovance Biotherapeutics.
    ViewRay, Inc. (NASDAQ: VRAY) rose 13.7 percent to $8.80 in pre-market trading after reporting upbeat quarterly earnings.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 5.6 percent to $32.00 in pre-market trading after falling 2.26 percent on Thursday.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 5.6 percent to $9.30 in pre-market trading after reporting Q3 results.
    Aflac Incorporated (NYSE: AFL) rose 4.7 percent to $47.50 in pre-market trading.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 4.2 percent to $2.24 in pre-market trading following Q1 earnings.
    Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS) shares rose 3.7 percent to $11.00 in pre-market trading after the company reported Q1 earnings.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Lisa Levin] Gainers
    ARMO BioSciences, Inc. (NASDAQ: ARMO) shares rose 67.5 percent to $49.96 in pre-market trading after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share.
    Turtle Beach Corporation (NASDAQ: HEAR) rose 62.8 percent to $11.30 in pre-market trading after the company reported Q1 results and raised its FY18 outlook.
    vTv Therapeutics Inc. (NASDAQ: VTVT) rose 23.4 percent to $2.11 in pre-market trading following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June.
    Resonant Inc. (NASDAQ: RESN) rose 19.1 percent to $5.00 in pre-market trading after reporting Q1 results.
    RXi Pharmaceuticals Corporation (NASDAQ: RXII) rose 17.7 percent to $2.39 in pre-market trading following Q1 results.
    Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 15.2 percent to $2.20 in pre-market trading after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million.
    Everspin Technologies, Inc. (NASDAQ: MRAM) rose 14.6 percent to $8.50 in pre-market trading after the company reported strong results for its first quarter.
    Carvana Co. (NYSE: CVNA) shares rose 11 percent to $27.50 in pre-market trading after reporting upbeat Q1 sales.
    Sunrun Inc. (NASDAQ: RUN) rose 8.9 percent to $10.70 in pre-market trading following upbeat quarterly earnings.
    MediciNova, Inc. (NASDAQ: MNOV) rose 8.1 percent to $11.35 in pre-market trading after the company announced opening of Investigational New Drug Application for MN-166 (ibudilast) in glioblastoma.
    New Gold Inc. (NYSE: NGD) shares rose 7.7 percent to $2.65 in pre-market trading after the company reported that its President and CEO Hannes Portmann left the company. The company named Raymond Threlkeld as successor.
    Otter Tail Corporation (NASDAQ: OTTR) shares rose 7.4 percent to $46.60 in the pre-market trading session.
    Himax Technologies, Inc. (NASDAQ: HIMX) shares rose
  • [By Shane Hupp]

    These are some of the news headlines that may have impacted Accern Sentiment’s scoring:

    Get RXi Pharmaceuticals alerts:

    New Research Study on Connective Tissue Growth Factor Market 2018 to 2025 (morningoutlook.com) Hypoxia Inducible Factor 1 Alpha Market Pipeline Therapeutics H1, 2018 Product Description, Mechanism of Action … (exclusiveherald.com) Human Papillomavirus Associated Diseases Market Pipeline Therapeutics 2018 Drug Description, Target Finding, and … (thefreenewsman.com) Warts Market Therapeutic Pipeline H1, Drugs, Diagnostics, Vaccines and Preventive Technologies (newspublicist.com) Brokerages Anticipate RXi Pharmaceuticals Corp (RXII) to Post -$0.56 Earnings Per Share (americanbankingnews.com)

    Shares of RXi Pharmaceuticals traded down $0.01, hitting $2.24, on Tuesday, MarketBeat Ratings reports. 55,400 shares of the stock were exchanged, compared to its average volume of 275,015. The company has a market capitalization of $9.96 million, a price-to-earnings ratio of -0.53 and a beta of 1.15. RXi Pharmaceuticals has a one year low of $1.90 and a one year high of $7.70.

  • [By Shane Hupp]

    These are some of the media headlines that may have impacted Accern Sentiment Analysis’s scoring:

    Get RXi Pharmaceuticals alerts:

    Intercellular Adhesion Molecule 1 Market Pipeline Review H1 Products in Clinical Stage, Methodology, therapeutic … (talkinvestor.com) Hypoxia Inducible Factor 1 Alpha Market Research Report H1: Drug Profile, Top Industry Intelligence and Therapeutic … (thestockanalysis.com) Connective Tissue Growth Factor Market Opportunities, Demands, Size, Share, Trends, Industry Sales Area and Its … (trueindustrynews.com) Global Connective Tissue Growth Factor Market 2018 Manufacturing Analysis and Development Forecast 2025 (trueindustrynews.com) Zacks: Analysts Expect RXi Pharmaceuticals Corp (RXII) to Announce -$0.56 EPS (americanbankingnews.com)

    Shares of RXi Pharmaceuticals stock traded down $0.04 on Tuesday, hitting $1.92. The company had a trading volume of 27,600 shares, compared to its average volume of 258,173. The stock has a market capitalization of $8.21 million, a PE ratio of -0.46 and a beta of 1.20. RXi Pharmaceuticals has a 52 week low of $1.90 and a 52 week high of $7.70.

Top Stocks To Watch Right Now: Equinix Inc.(EQIX)

Advisors’ Opinion:

  • [By Max Byerly]

    Front Row Advisors LLC increased its position in Equinix Inc (NASDAQ:EQIX) by 7.4% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,175 shares of the financial services provider’s stock after buying an additional 150 shares during the quarter. Front Row Advisors LLC’s holdings in Equinix were worth $909,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Lee Jackson]

    This is one of the larger cap companies in the data center arena and a top play for more conservative accounts. Equinix Inc. (NASDAQ: EQIX) provides data center services to protect and connect the information assets for the enterprises, financial services companies, and content and network providers primarily in the Americas, Europe, the Middle East, Africa and the Asia-Pacific.

  • [By Stephan Byrd]

    Credit Suisse Group set a $525.00 price objective on Equinix (NASDAQ:EQIX) in a research report report published on Friday. The firm currently has a buy rating on the financial services provider’s stock.

  • [By Stephan Byrd]

    US Bancorp DE boosted its holdings in Equinix (NASDAQ:EQIX) by 12.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,159 shares of the financial services provider’s stock after purchasing an additional 920 shares during the quarter. US Bancorp DE’s holdings in Equinix were worth $3,411,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Equinix (EQIX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Matthew Frankel]

    Equinix (NASDAQ:EQIX) is the largest operator of data centers in the world, with more than 9,800 companies utilizing its properties. The company provides the facility, power, security, and cooling equipment for its customers, and they supply their own servers and networking equipment.

Top Stocks To Watch Right Now: Western Copper and Gold Corporation(WRN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Western Copper (NYSEAMERICAN:WRN) (TSE:WRN) was the recipient of a large increase in short interest in June. As of June 15th, there was short interest totalling 367,976 shares, an increase of 17.9% from the May 31st total of 312,021 shares. Based on an average daily trading volume, of 131,386 shares, the short-interest ratio is currently 2.8 days.

Top Stocks To Watch Right Now: T2 Biosystems, Inc.(TTOO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of T2 Biosystems, Inc. (NASDAQ: TTOO) were down 12 percent to $7.80 after the health care company that targets unmet needs received clearance from the FDA. The company said the FDA granted a market clearance for its T2Bacteria Panel for the direct detection of bacterial species in human whole blood specimens from patients with suspected bloodstream infections.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Co-Diagnostics, Inc. (NASDAQ: CODX) fell 11.6 percent to $3.13 in pre-market trading after surging 118.52 percent on Tuesday.
    Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) shares fell 6.5 percent to $2.60 in pre-market trading after rising 1.09 percent on Tuesday.
    T2 Biosystems, Inc. (NASDAQ: TTOO) fell 6 percent to $7.58 in pre-market trading after dropping 9.13 percent on Tuesday.
    Era Group Inc. (NYSE: ERA) fell 4.8 percent to $12.30 in the pre-market trading session.
    DSW Inc. (NYSE: DSW) shares fell 4.1 percent to $25.00 in pre-market trading after reporting Q1 results.
    ZTO Express (Cayman) Inc. (NYSE: ZTO) shares fell 2.7 percent to $20.25 in pre-market trading after rising 7.88 percent on Tuesday.
    Daktronics, Inc. (NASDAQ: DAKT) fell 2.5 percent to $9.81 in pre-market trading. Daktronics is expected to release quarterly earnings today.
    AngloGold Ashanti Limited (NYSE: AU) fell 2.2 percent to $8.28 in pre-market trading

  • [By Logan Wallace]

    HC Wainwright reiterated their buy rating on shares of T2 Biosystems (NASDAQ:TTOO) in a report issued on Thursday morning. The firm currently has a $14.00 target price on the medical equipment provider’s stock.

  • [By Max Byerly]

    T2 Biosystems (NASDAQ:TTOO) was upgraded by research analysts at ValuEngine from a “hold” rating to a “buy” rating in a research note issued to investors on Friday.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on T2 Biosystems (TTOO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Maxx Chatsko]

    Shares of diagnostic test and device developer T2 Biosystems (NASDAQ:TTOO) jumped as much as 16.1% today after a volatile week. The good news is that the company recently announced that the U.S. Food and Drug Administration cleared its T2Bacteria Panel, which is aimed at detecting the presence of sepsis-causing pathogens in blood samples.

Best Tech Stocks To Buy For 2019

Google CEO Sundar Pichai and other California tech titans have been up in arms over immigration because they fear the Trump administration will target a visa program they cherish for bringing in engineers and other specialized workers from other countries, primarily India. (AP Photo/Tsering Topgyal, File)

If Silicon Valley thought that crackdowns on immigration in the U.S. would mean their favorite foreign worker would be hightailing it back to Bangalore, they are wrong.  First, India as an outsourcing power and exporter of human capital isn’t going away anytime soon. Second, the H-1B visa issue that is overwhelmingly going to Indian computer geeks at Indian companies may see more Indian computer geeks going to American ones like Amazon instead; and three, the big Indian outsourcers would have to totally revamp their business model if they were to repatriate. To date, most of the profits at places like Tata Consultancy Services and Wipro are all coming from the U.S. and Europe. They need workers here.

Best Tech Stocks To Buy For 2019: Guidewire Software, Inc.(GWRE)

Advisors’ Opinion:

  • [By Monica Gerson]

    Guidewire Software Inc (NYSE: GWRE) is estimated to post its quarterly earnings at $0.06 per share on revenue of $92.43 million.

    Analogic Corporation (NASDAQ: ALOG) is projected to post its quarterly earnings at $0.88 per share on revenue of $127.30 million.

  • [By Stephan Byrd]

    TRADEMARK VIOLATION NOTICE: “Insider Selling: Guidewire Software (GWRE) Insider Sells 209 Shares of Stock” was first posted by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another site, it was copied illegally and reposted in violation of international copyright and trademark laws. The correct version of this story can be viewed at www.tickerreport.com/banking-finance/3365485/insider-selling-guidewire-software-gwre-insider-sells-209-shares-of-stock.html.

  • [By Peter Graham]

    A long term performance chart shows Ebix Inc actually performing well since the end of 2014 while mid cap peer Guidewire Software Inc (NYSE: GWRE) has been outperforming over a longer period of time and small cap Benefitfocus Inc (NASDAQ: BNFT) has underperformed:

Best Tech Stocks To Buy For 2019: Rudolph Technologies Inc.(RTEC)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 73.3 percent to $3.90.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares gained 51 percent to $33.1365. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Monaker Group, Inc. (NASDAQ: MKGI) shares jumped 34 percent to $3.00.
    Sharing Economy International Inc. (NASDAQ: SEII) shares rose 28.2 percent to $4.51 after gaining 9.32 percent on Wednesday.
    STAAR Surgical Company (NASDAQ: STAA) shares jumped 27.8 percent to $21.40 after reporting upbeat Q1 results.
    Boxlight Corporation (NASDAQ: BOXL) rose 20.5 percent to $8.920 after climbing 107.87 percent on Wednesday.
    Xspand Products Lab Inc (NASDAQ: XSPL) gained 19.5 percent to $ 5.97. Xspand Products priced its IPO at $5 per share.
    YRC Worldwide Inc. (NASDAQ: YRCW) rose 18.9 percent to $10.035 following upbeat quarterly earnings.
    ENDRA Life Sciences Inc. (NASDAQ: NDRA) gained 18.3 percent to $3.0177. ENDRA Life Sciences is expected to report Q1 results on May 15.
    MYR Group Inc. (NASDAQ: MYRG) rose 18.1 percent to $35.85 after the company posted strong Q1 earnings.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares jumped 16 percent to $30.75 following upbeat quarterly earnings.
    TTM Technologies, Inc. (NASDAQ: TTMI) gained 13.7 percent to $16.53 after reporting Q1 results.
    Insight Enterprises, Inc. (NASDAQ: NSIT) shares surged 12 percent to $40.06 following better-than-expected Q1 earnings.
    TreeHouse Foods, Inc. (NYSE: THS) rose 11.8 percent to $40.93 following Q1 results.
    Engility Holdings, Inc. (NYSE: EGL) surged 11.2 percent to $27.36. Engility reported upbeat quarterly earnings.
    Synalloy Corporation (NASDAQ: SYNL) rose 10.7 percent to $19.10 following Q1 results.
    Logitech International S.A. (NASDAQ: LOGI)
  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 155.56 percent to close at $5.75 on Thursday.
    Inspire Medical Systems, Inc. (NYSE: INSP) shares gained 56.12 percent to close at $24.98. Inspire Medical went public Thursday on the New York Stock Exchange. The company issued 6.75 million shares priced at $16 each.
    Presbia PLC (NASDAQ: LENS) shares rose 53.02 percent to close at $3.55.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares rose 46.29 percent to close at $32.11. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Technical Communications Corporation (NASDAQ: TCCO) climbed 27.78 percent to close at $5.75.
    STAAR Surgical Company (NASDAQ: STAA) shares gained 26.27 percent to close at $21.15 after reporting upbeat Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares jumped 22.16 percent to close at $4.30 on Thursday after gaining 9.32 percent on Wednesday.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) rose 20.45 percent to close at $2.65 on Thursday.
    YRC Worldwide Inc. (NASDAQ: YRCW) surged 18.36 percent to close at $9.99 following upbeat quarterly earnings.
    MYR Group Inc. (NASDAQ: MYRG) jumped 17.68 percent to close at $35.74 after the company posted strong Q1 earnings.
    Xspand Products Lab Inc (NASDAQ: XSPL) jumped 17.4 percent to close at $5.87. Xspand Products priced its IPO at $5 per share.
    Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose 17.32 percent to close at $14.90. Coherus BioSciences reported resubmission of BLA for CHS-1701.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares gained 17.17 percent to close at $31.05 following upbeat quarterly earnings.
    The Meet Group, Inc. (NASDAQ: MEET) gained 16.02 percent to close at $2.68 following Q1 earnings.
    Ca

Best Tech Stocks To Buy For 2019: GigaMedia Limited(GIGM)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggested small cap online gaming and cloud computing GigaMedia Limited (NASDAQ: GIGM) as a bullish long trade:

Best Tech Stocks To Buy For 2019: Intersil Corporation(ISIL)

Advisors’ Opinion:

  • [By Scott Rubin]

    Big gainers on the day included Intersil Corp (NASDAQ: ISIL), which jumped 20 percent on news of a buyout, and Medivation (NASDAQ: MDVN), which added 20 percent on a deal with Pfizer (NYSE: PFE) related to its cancer drug. Cotiviti Holdings Inc (NYSE: COTV) lost around 9 percent in the wake of a mid-day sell-off and Marathon Oil Corporation (NYSE: MRO) fell 7 percent in the wake of a management shakeup.

Best Tech Stocks To Buy For 2019: Finisar Corporation(FNSR)

Advisors’ Opinion:

  • [By Anders Bylund]

    Finisar(NASDAQ:FNSR) followed in AAOI’s footsteps in March, surging more than 10% higher around the announcement of Lumentum’s Oclaro deal, but losing it all amid deafening radio silence. By the end of March, the stock had fallen 12.2% lower, and Finisar has not enjoyed any glowing analyst analyses in April.

  • [By Peter Graham]

    Small cap fiber-optic networking product Applied Optoelectronics (NASDAQ: AAOI), a potential peer of EMCORE Corporation (NASDAQ: EMKR), Finisar Corporation (NASDAQ: FNSR) and Oclaro Inc (NASDAQ: OCLR), is thefifth mostshorted stock on theNASDAQ with short interest of 47.69% according to Highshortnterest.com.

  • [By Peter Graham]

    Small cap fiber-optic networking product Applied Optoelectronics (NASDAQ: AAOI), a potential peer of EMCORE Corporation (NASDAQ: EMKR), Finisar Corporation (NASDAQ: FNSR) and Oclaro Inc (NASDAQ: OCLR), is themostshorted stock on theNASDAQ with short interest of 62.65% according to Highshortnterest.com.

  • [By Paul Ausick]

    Finisar Corp. (NASDAQ: FNSR) posted a new 52-week low of $17.81 Monday, down about 7.5% after closing at $19.26 on Friday. The 52-week high is $36.85. Volume was about 6.4 million, nearly double the daily average of around 3.4 million shares. The optical technology company had no specific news.

  • [By Dan Caplinger]

    The stock market had a negative tone on Wednesday, although major benchmarks moved in different directions. The Dow Jones Industrials took the biggest hit, falling triple digits as one of its most influential components suffered an earnings-related drop. Relative strength in the Nasdaq Composite showed cross-currents in the overall market, but several individual stocks had substantial declines for the day, andRite Aid (NYSE:RAD), Diana Shipping (NYSE:DSX), and Finisar (NASDAQ:FNSR) were among the worst performers. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

Best Tech Stocks To Buy For 2019: Equinix Inc.(EQIX)

Advisors’ Opinion:

  • [By Lee Jackson]

    This is one of the larger capitalization companies in the data center industry. Equinix Inc. (NASDAQ: EQIX)provides data center services to protect and connect the information assets for the enterprises, financial services companies, and content and network providers primarily in the Americas, Europe, the Middle East, Africa and the Asia-Pacific.

  • [By Beth McKenna]

    Equinix (NASDAQ:EQIX) reported robust first-quarter 2018 financial results after the market close on Wednesday.

    Shares closed down 6.1% on Thursday, which we can probably attribute to the company revising slightly downward its full-year 2018 adjusted funds from operations (AFFO) outlook, as we’ll get to in a moment. (AFFO is aclosely watched metric for companies organized as real estate investment trusts, or REITs. It’s akin to “earnings” for REITs.)

Top Low Price Stocks To Watch For 2019

Q: The stock market seems to be reaching new record highs every day. Are there any stocks that still look cheap?

Corporate earnings have exhibited pretty impressive growth as a whole over the past few years, so the market’s performance is somewhat justified. However, many stocks do look to be rather expensive right now — particularly in the tech sector. Yet some bargains remain.

One of my favorite “cheap” stocks right now is AT&T (NYSE: T), even after shares popped following the company’s strong quarterly report. The telecom giant pays a dividend yielding more than 5% and is a Dividend Aristocrat, meaning that it has increased its dividend for more than 25 consecutive years.

Despite a low price-to-earnings multiple of just 13 times 2017’s expected earnings, AT&T has lots of room to grow, especially thanks to its purchase of DIRECTV and its pending acquisition of Time Warner, both of which should give it an advantage over the competition when it comes to bundling services and broadcasting content directly to smartphones and tablets.

Top Low Price Stocks To Watch For 2019: Equinix Inc.(EQIX)

Advisors’ Opinion:

  • [By Lee Jackson]

    This is one of the larger capitalization companies in the data center industry. Equinix Inc. (NASDAQ: EQIX)provides data center services to protect and connect the information assets for the enterprises, financial services companies, and content and network providers primarily in the Americas, Europe, the Middle East, Africa and the Asia-Pacific.

Top Low Price Stocks To Watch For 2019: Clean Diesel Technologies Inc.(CDTI)

Advisors’ Opinion:

  • [By Monica Gerson]

    Clean Diesel Technologies, Inc. (NASDAQ: CDTI) is projected to post a quarterly loss at $0.18 per share on revenue of $10.25 million.

    Sphere 3D Corp. (NASDAQ: ANY) is estimated to post a quarterly loss at $0.11 per share on revenue of $22.10 million.

Top Low Price Stocks To Watch For 2019: First Capital Bancorp Inc.(VA)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows JetBlue Airways Corporation giving a good performance thats still not as good as that of large cap Southwest Airlines Co (NYSE: LUV) while the performance ofAlaska Air Group, Inc (NYSE: ALK), which has acquired Virgin America Inc (NASDAQ: VA), seems to have slipped recently:

Top Low Price Stocks To Watch For 2019: Trevena, Inc.(TRVN)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By Chris Lange]

    Trevena Inc. (NASDAQ: TRVN) reported positive results from two late-stage clinical trials that work to treat post-surgical pain. The company intends to submit these results to the FDA for a marketing approval agreement in the fourth quarter. Previously, oliceridine was approved for a breakthrough designation by the agency.

  • [By Maxx Chatsko]

    Shares of clinical-stage biopharma Trevena (NASDAQ:TRVN) fell nearly 12% today after it reported full-year 2016 earnings. The pre-revenue company didn’t announce any surprises one way or the other. However, investors appear to be considering the near-term consequences of swelling expenses that won’t be offset by product sales anytime soon.

  • [By Paul Ausick]

    Trevena Inc. (NASDAQ: TRVN) dropped about 6.3% Thursday, to post a new 52-week low of $3.70 after closing at $3.95 on Wednesday. The stock’s 52-week high is $9.73. Volume was nearly 5 times the daily average of around 700,000 shares. The company’s pain-killing drug got mixed results in a trial result reported Tuesday.

  • [By Lisa Levin]

    Trevena Inc (NASDAQ: TRVN) shares dropped 36 percent to $4.55 despite a positive development in Phase 3 trials. Trevena announced positive top-line results from ongoing Phase 3 trials called "APOLLO-1" and "APOLLO-2." The studies evaluated the safety of Trevena's oliceridine therapy in patients for 48 hours following bunionectomy and 24 hours following abdominoplasty.

Top 10 Medical Stocks For 2018

Despite staggering increases in drug prices, Americans still aren’t living as long as those in other countries. And the worst part is they’re paying more, too…

One out of every four Americans reported that the cost of healthcare is their primary concern right now, according to a January 2017 Monmouth University poll. In fact, anxiety about paying medical bills now outpaces job and unemployment concerns, as well as worries about paying everyday household bills.

And it’s no wonder: In August, prices for medicine, doctor’s appointments, and health insurance rose at rates not seen since 1984.

Drug costs, in particular, are growing by double and triple digits each year. Back in October 2016, The Fiscal Times reported that specialty drug prices grew 18.9% and are projected to increase another 18.7% this year. Additionally, it reported that generic drug prices are expected to increase another 11% this year after already going up 11.3% in 2016.

Top 10 Medical Stocks For 2018: HP Inc.(HPQ)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, technology shares fell 0.11 percent. Meanwhile, top losers in the sector included HP Inc (NYSE: HPQ), down 7 percent, and iRobot Corporation (NASDAQ: IRBT) down 8 percent.

  • [By Alex Cho]

    That being the case, it wouldnt take substantial market share gains for AMD to reverse the multi-year decline in its processor business, as performance/watt is what will drive adoption from key PC makers like Dell, HP Inc (NYSE:HPQ)and Lenovo. AMD hasnt been very competitive in the MPU (microprocessor unit) segment for quite a while, but given the recent node shift to 14nm FinFET over at GlobalFoundries, and mention of new architecture by AMD earlier this year at COMPUTEX Taiwan, I get the impression that performance of Summit Ridge, i.e. Zen will match Skylake and will perhaps come in slightly slower than Kaby Lake.

  • [By Peter Graham]

    Small cap 3D printing stockStratasys, Ltd (NASDAQ: SSYS)reported Q1 earnings before the market opened this morning that met expectations, but shares are falling as much as 10% in premarket trading given the run-up the stock has already had. Stratasys is the largest U.S. manufacturer of 3D printers by revenue whileHP Inc (NYSE: HPQ), which has recently entered the3D printer market,is already number two. Nevertheless,it appears that 3D printing stockshave at least stabilized as the short interest has largely been cleared out.

  • [By Paul Ausick]

    Fourth-quarter 2017 shipments of personal computers (PCs), including desktops and laptops, fell 2% year over year to an estimated 71.56 million units. HP Inc. (NYSE: HPQ) was the volume and market-share leader with worldwide shipments totaling 16.08 million in the quarter and a share of 22.5%. For the full year, worldwide shipments dipped 2.8% to 262.54 million units.

  • [By Teresa Rivas]

    HP Inc. (HPQ) rose to the top of the S&P 500 Wednesday.

    Agence France-Presse/Getty Images

    The shares climbed 48 cents, or 2.7%, to $18.02, compared to the S&P 500, which lost 8.85 points, or 0.38%, to 2344.93.

    HP was helped by data from IDC that showed the firm regained the crown of top PC vendor from rival Levono Group in Q1.

    In addition, Morgan Stanleys Katy Huberty reiterated an Overweight rating on HP and increased her price target to $22 from $19:

    In the past 18 months, HP removed over $1B of excess costs and refocused investment dollars on driving innovation across printing and personal systems. Recent product refreshes, including JetIntelligence laser printers, Sprocket mobile photo printer, and premium and gaming/VR-focused PCs are now driving share gains and a return to top-line growth (total revenue grew 2% and 4% Y/Y in last two fiscal quarters, respectively). By reinventing HP, we believe management is heralding a new era for the company whereby investors can expect greater confidence in top-line stabilization as well as earnings and FCF durability.

    Yesterday, American Airlines(AAL)was the best performing stock in the S&P 500.

Top 10 Medical Stocks For 2018: TRC Companies Inc.(TRR)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of TRC Companies, Inc. (NYSE: TRR) got a boost, shooting up 16 percent to $7.53. TRC posted Q4 earnings of $0.20 per share on revenue of $132.3 million.

Top 10 Medical Stocks For 2018: Equinix Inc.(EQIX)

Advisors’ Opinion:

  • [By Lee Jackson]

    This is one of the larger capitalization companies in the data center industry. Equinix Inc. (NASDAQ: EQIX)provides data center services to protect and connect the information assets for the enterprises, financial services companies, and content and network providers primarily in the Americas, Europe, the Middle East, Africa and the Asia-Pacific.

Top 10 Medical Stocks For 2018: Anadarko Petroleum Corporation(APC)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    One of the largest projects is the Saddlehorn Pipeline, which Magellan is building with Plains All American Pipeline (NYSE:PAA) and Anadarko Petroleum (NYSE:APC). Both Plains All American Pipeline and Magellan own 40% of the project, which puts their total investment at $230 million apiece. They expect the project to be fully operational early next year, which is noteworthy given its robust first-year economics. Magellan estimates that it will earn eight times EBITDA on the capital deployed, or roughly $28.8 million in annual EBITDA apiece for Magellan and Plains All American Pipeline on their investment.

  • [By Lisa Levin]

    Shares of Sanchez Energy Corp (NYSE: SN) got a boost, shooting up 28 percent to $11.11. Anadarko Petroleum Corporation (NYSE: APC) announced the sale of Eagleford Shale assets to Sanchez Energy and Blackstone Energy Partners for $2.3 billion.

  • [By WWW.GURUFOCUS.COM]

    For the details of Packer & Co Ltd’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Packer+%26+Co+Ltd

    These are the top 5 holdings of Packer & Co LtdBall Corp (BLL) – 625,005 shares, 7.52% of the total portfolio. Hess Corp (HES) – 2,039,400 shares, 6.78% of the total portfolio. Anadarko Petroleum Corp (APC) – 1,432,600 shares, 6.35% of the total portfolio. Shares added by 14.37%Citigroup Inc (C) – 604,500 shares, 6.34% of the total portfolio. Shares reduced by 11.04%General Electric Co (GE) – 1,118,800 shares, 5.98% o

  • [By Matthew DiLallo]

    While crude prices stumbled into 2016, they found their footing by mid-year and roared back to life, ending the year up about 42%. Those rising prices lifted most oil stocks. However, a handful of large-cap oil stocks rose above the crowd by outperforming crude’s rally. Those top-tier performers wereContinental Resources (NYSE:CLR), Devon Energy (NYSE:DVN), Anadarko Petroleum (NYSE:APC), Pioneer Natural Resources (NYSE:PXD), and Cimarex Energy (NYSE:XEC):

Top 10 Medical Stocks For 2018: Sonoco Products Company(SON)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Deutsche Bank’s Debbie Jones and team contend that Sonoco’s (SON) sale of its plastic-container business to Australia’s Amcor is a sign that M&A is in the offing. They explain why:

    Sonoco announced (9/1) that it is selling its Rigid Plastics Blow Molding operations to Amcor (AMC.AU) for $280M. The transaction price represents a multiple of ~8.0x LTM EBITDA. The business had annual sales of ~$210M and consisted of six production sites in the US and one in Canada. Blow molding operations represented ~10% of Sonocos Consumer Packaging segment sales and EBITDA. The transaction is expected to close in Q4. We expect the proceeds to be used to for M&A focused in flexible packaging, thermoforming and temperature-assured packaging.

    We dont believe Sonoco considered its blow molding operations essential to its growth strategy. This standalone business is also more capital intensive compared to some of its other plastic packaging businesses and SON held a small position in the overall market. Ultimately, the company decided it wants to focus its capital in higher growth platforms. We do not expect the divestment to reduce resin buying scale for Sonoco’s remaining assets given different resin buying. Note that with the divestiture of blow molding and the Canton closures plant (divested in Feb. 2015), this makes the ~$100M reels business the last standalone business in the portfolio, but we do not expect this to be divested in the near-term unless cash is needed for much larger M&A.

    Shares of Sonoco have gained 1.3% to $52.49 at 2:12 p.m. today.

     

Top 10 Medical Stocks For 2018: Utilities Select Sector SPDR ETF (XLU)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    The Dow utility average ended last week at a stabilizing 639.95 after trading as low as 616.19 on Nov. 14. Keep in mind that a “death cross” was confirmed on election day, when the 50-day simple moving average fell below the 200-day simple moving average, indicating that lower prices are likely ahead. The 200-day is now at 666.30. The utility average has returned to my range of key levels of 635.23 and 670.81, which remain magnets for the remainder of 2016. This week’s value level is above the Nov. 14 low at 620.87. Investors seeking the safety of dividends can trade the Utilities Select Sector SPDR Fund (XLU) , which is a basket of 28 utility stocks.

  • [By Craig Jones]

    On CNBC's Options Action, Dan Nathan suggested a bearish options trading idea in Utilities SPDR (ETF) (NYSE: XLU).

    The stock caught his attention, because he noticed a big put options volume last week in the name. He thinks traders should not be in the stock ahead of a possible rate hike.

  • [By ]

    High-yield and traditionally-safe sectors like Utilities, represented by the Utilities Select Sector SPDR (NYSE: XLU), and Consumer Staples, represented by the Consumer Staples Select Sector SPDR (NYSE: XLP), show this relationship with yields.

  • [By Craig Jones]

    Speaking on Bloomberg Markets, Kevin Kelly of Recon Capital Partners suggested that investors with a long position in Utilities SPDR (ETF) (NYSE: XLU) should consider an options strategy that offers protection ahead of the FOMC meeting.

Top 10 Medical Stocks For 2018: American Eagle Outfitters, Inc.(AEO)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of American Eagle Outfitters (NYSE: AEO) were down 12 percent to $11.35 after the company posted downbeat quarterly earnings and issued a weak earnings forecast for the current quarter.

  • [By Leo Sun]

    American Eagle Outfitters (NYSE:AEO) trades at 12 times earnings, which is half the industry average of 24 for apparel stores. It pays a forward dividend yield of 3.6%, which is much higher than the S&P 500’s average yield of 2%. That dividend is supported by a payout ratio of 43%, but it hasn’t hiked that payout since 2013.

  • [By Chris Lange]

    American Eagle Outfitters Inc. (NYSE: AEO) released its most recent quarterly results before the markets opened on Thursday. This company joins an increasing number of retailers that saw their earnings fall flat during the fourth quarter. Most recently we saw Dollar Tree and Kroger slip.

Top 10 Medical Stocks For 2018: Principal Financial Group Inc(PFG)

Advisors’ Opinion:

  • [By Ben Levisohn]

    The twenty stocks in Worth’s basket are: Ameriprise Financial (AMP) Bank of America, Banner (BANR), Citigroup, Citizens Financial Group (CFG), East West Bancorp (EWBC), First NBC Bank Holding (FNBC), HFF (HF), KeyCorp(KEY), Legacy Texas Financial Group (LTXB), Lincoln National (LNC), Morgan Stanley, Old National Bancorp (ONB), PacWest Bancorp (PACW), PNC Financial Services Group (PNC), Principal Financial Group (PFG), Stifel Financial (SF), SVB Financial Group (SIVB), TCF Financial (TCB), and Wells Fargo.

Top 10 Medical Stocks For 2018: Seres Therapeutics, Inc.(MCRB)

Advisors’ Opinion:

  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares dropped 70 percent to $10.69 after the company reported interim results from SER-109 Phase 2 ECOSPOR study in multiply recurrent clostridium difficile infection. The study did not achieve primary endpoint.

  • [By Lisa Levin]

    Seres Therapeutics Inc (NASDAQ: MCRB) shares shot up 35 percent to $12.51. Seres Therapeutics reported initiation of new SER-019 study announced FY16 loss of $2.30 per share on revenue of $21.766 million.

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than

Top 10 Medical Stocks For 2018: Facebook, Inc.(FB)

Advisors’ Opinion:

  • [By Adam Levy]

    Facebook (NASDAQ:FB) is a global phenomenon. Even with 1.86 billion monthly active users as of the end of 2016, the company is still growing its user base at a fairly steady clip in the high teens.

  • [By Ravi Bala]

    Although there is a lot of hype surrounding Virtual Reality (VR) and Facebook’s(NSDQ:FB) Oculus Rift, I have to say that this is not a game changer. In fact, it has been around before. Nintendo was one of the first companies to do this with their virtual boy. However, the outing was considered a colossal failure due to the high price and nascent technology. As times have changed, the capabilities of this technology have gotten better. However, pricing may be the ultimate determinant of who succeeds or wins. Here’s why the Oculus acquisition may turn out to be a bad move and may hurt FB stock.

  • [By Money Morning Staff Reports]

    The former – led by Facebook Inc. (Nasdaq: FB) and Twitter Inc. (NYSE: TWTR), for example – are going to get clobbered, while the broader pullback will give savvy investors in the latter a massive and potentially very profitable opportunity.